Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS^® hydromorphone ER) in patients with chronic pain

References

• TurkDCOkifujiAPain terms and taxonomies of painFishmanSMBallantyneJCRathmellJPBonica’s Management of Pain4th edBaltimore, MDLippincott Williams & Wilkins20101323
   Google Scholar
• US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health StatisticsHealth, United States, 2006: with Chartbook on Trends in the Health of AmericansDHHS Publication No 2006-1232Hyattsville, MDNational Center for Health Statistics2006 Available from: http://www.cdc.gov/nchs/data/hus/hus06.pdfAccessed June 27, 2011
   Google Scholar
• US Census BureauPreliminary Annual Estimates of the Resident Population for the United States, Regions, States, and Puerto Rico: April 1, 2000 to July 1, 2010 (NSTPEST2010-01)2002 estimate Available from: http://www.census.gov/popest/research/eval-estimates/eval-es+2010.htmlLast accessed April 4, 2012
   Google Scholar
• McCarbergBHNicholsonBDToddKHPalmerTPenlesLThe impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet surveyAm J Ther200815431232018645331
   PubMed Web of Science ®Google Scholar
• TurkDCWilsonHDCahanaATreatment of chronic non-cancer painLancet201137797842226223521704872
   PubMed Web of Science ®Google Scholar
• ChouRFanciulloGJFinePGAmerican Pain Society-American Academy of Pain Medicine Opioids Guidelines PanelClinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
   PubMed Web of Science ®Google Scholar
• ArgoffCESilversheinDIA comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needsMayo Clin Proc200984760261219567714
   PubMed Web of Science ®Google Scholar
• HerreroJFLairdJMLópez-GarcíaJAWind-up of spinal cord neurones and pain sensation: much ado about something?Prog Neurobiol200061216920310704997
   PubMed Web of Science ®Google Scholar
• FinePGMahajanGMcPhersonMLLong-acting opioids and short-acting opioids: appropriate use in chronic pain managementPain Med200910Suppl 2S79S8819691687
   PubMed Web of Science ®Google Scholar
• QuigleyCWiffenPA systematic review of hydromorphone in acute and chronic painJ Pain Symptom Manage200325216917812590032
   PubMed Web of Science ®Google Scholar
• QuigleyCHydromorphone for acute and chronic painCochrane Database Syst Rev20021CD00344711869661
   PubMedGoogle Scholar
• KnotkovaHFinePGPortenoyRKOpioid rotation: the science and the limitations of the equianalgesic dose tableJ Pain Symptom Manage200938342643919735903
   PubMed Web of Science ®Google Scholar
• LawlorPTurnerKHansonJBrueraEDose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective studyPain1997721–279859272790
   PubMed Web of Science ®Google Scholar
• BrueraEPereiraJWatanabeSBelzileMKuehnNHansonJOpioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphineCancer19967848528578756381
   PubMed Web of Science ®Google Scholar
• MercadanteSCaraceniAConversion ratios for opioid switching in the treatment of cancer pain: a systematic reviewPalliat Med201125550451521708857
   PubMed Web of Science ®Google Scholar
• MahlerDLForrestWHJrRelative analgesic potencies of morphine and hydromorphone in postoperative painAnesthesiology197542560260748347
   PubMed Web of Science ®Google Scholar
• Exalgo (hydromorphone HCl) extended-release tablets CII [package insert]Hazelwood, MOMallinckrodt2010
   Google Scholar
• DroverDRAngstMSValleMInput characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteersAnesthesiology200297482783612357147
   PubMed Web of Science ®Google Scholar
• SathyanGXuEThipphawongJGuptaSKPharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphoneBMC Clin Pharmacol20077317270058
   PubMedGoogle Scholar
• MooreKTSt-FleurDMarriccoNCSteady-state pharmacokinetics of extended-release hydromorphone (OROS hydromorphone): a randomized study in healthy volunteersJ Opioid Manag20106535135821046932
   PubMedGoogle Scholar
• CollinsSLFauraCCMooreRAMcQuayHJPeak plasma concentrations after oral morphine: a systematic reviewPain Symptom Manage1998166388402
   Web of Science ®Google Scholar
• TanGJensenMPThornbyJLShantiBFValidation of the Brief Pain Inventory for chronic nonmalignant painJ Pain20045213313715042521
   PubMed Web of Science ®Google Scholar
• NCI Thesaurus, Hoechst Adverse Reaction Terminology SystemThe National Center for Biomedical Ontology BioPortal website. http://bioportal.bioontology.org/ontologies/46317/?p-terms&conceptid=Hoescht_Adverse_Reaction_Terminology_SystemAdverse Reaction Terminology SystemAccessed October 5, 2012
   Google Scholar
• GuptaSSathyanGProviding constant analgesia with OROS® hydromorphoneJ Pain Symptom Manage200733Suppl 2S19S24
   Web of Science ®Google Scholar
• HannaMTucaAThipphawongJAn open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer painBMC Palliat Care200981419754935
   PubMedGoogle Scholar
• TurgeonJGröningRSathyanGThipphawongJRicharzUThe pharmacokinetics of a long-acting OROS hydromorphone formulationExpert Opin Drug Deliv20107113714419961358
   PubMed Web of Science ®Google Scholar
• AngstMSDroverDRLötschJPharmacodynamics of orally administered sustained-release hydromorphone in humansAnesthesiology2001941637311135723
   PubMed Web of Science ®Google Scholar
• TingNDose Finding in Drug DevelopmentNew York, NYSpringer2006
   Google Scholar
• PortenoyRKBennettDSRauckRPrevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer painJ Pain20067858359116885015
   PubMed Web of Science ®Google Scholar
• Parsells KellyJCookSFKaufmanDWAndersonTRosenbergLMitchellAAPrevalence and characteristics of opioid use in the US adult populationPain2008138350751318342447
   PubMed Web of Science ®Google Scholar
• KalsoEEdwardsJEMooreRAMcQuayHJOpioids in chronic non-cancer pain: systematic review of efficacy and safetyPain2004112337238015561393
   PubMed Web of Science ®Google Scholar
• RicharzUWaechterSSabatowskiRSzczepanskiLBinsfeldHSustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS(®) hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer PainPain Pract2012 Epub Apr 18
   Web of Science ®Google Scholar
• WallaceMMoulinDERauckRLLong-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic painJ Opioid Manag2009529710519507806
   PubMedGoogle Scholar